CAS: 2119583-26-3
Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
Nilotinib EP Impurity E REF: 4Z-N-3111CAS: 2119583-26-3 | - - - | A consultar | Ter 07 Jan 25 | |
N-[3-(1H-Imidazol-1-yl)-5-(trifluoromethyl)phenyl]-4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzamide REF: 3D-UJD58326CAS: 2119583-26-3 | Min. 95% | 310,00 €~1.449,00 € | Ter 18 Fev 25 | |
N-[3-(1H-Imidazol-1-yl)-5-(trifluoromethyl)phenyl]-4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]Benzamide REF: TR-I355005CAS: 2119583-26-3 | - - - | - - - | Produto descontinuado |
Nilotinib EP Impurity E
CAS:2119583-26-3
Fórmula:
C27H20F3N7O
Cor e Forma:
Off-White Solid
Peso molecular:
515.50
Ref: 4Z-N-3111
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Entrega estimada em Estados Unidos, Terça-feira 7 de Janeiro de 2025
N-[3-(1H-Imidazol-1-yl)-5-(trifluoromethyl)phenyl]-4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzamide
CAS:2119583-26-3
Please enquire for more information about N-[3-(1H-Imidazol-1-yl)-5-(trifluoromethyl)phenyl]-4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzamide including the price, delivery time and more detailed …
Fórmula:
C27H20F3N7O
Pureza:
Min. 95%
Peso molecular:
515.5 g/mol
Ref: 3D-UJD58326
1mg | 310,00 € | ||
2mg | 436,00 € | ||
5mg | 582,00 € | ||
10mg | 924,00 € | ||
25mg | 1.449,00 € |
Entrega estimada em Estados Unidos, Terça-feira 18 de Fevereiro de 2025
N-[3-(1H-Imidazol-1-yl)-5-(trifluoromethyl)phenyl]-4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]Benzamide
CAS:2119583-26-3
Applications N-[3-(1H-Imidazol-1-yl)-5-(trifluoromethyl)phenyl]-4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]Benzamide, is an imurtiy of Nilotinib (N465300), that might be useful in treatment of …
Fórmula:
C27H20F3N7O
Cor e Forma:
Pale Yellow to Pale Beige Solid
Peso molecular:
515.49
Ref: TR-I355005
5mg | Descontinuado | Solicitar informações | |
25mg | Descontinuado | Solicitar informações | |
50mg | Descontinuado | Solicitar informações |